Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00634816 · ClinicalTrials.gov registry record
Bone Mineral Density in Adult Survivors of Solid Pediatric Cancers
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Completed
- Registry status
- 38
- Enrollment target
NCT00634816: Completed study, sponsored by State University of New York - Upstate Medical University.
NCT00634816 is a clinical trial that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00634816 has completed, sponsored by State University of New York - Upstate Medical University.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
Specific subgroups of children who survive treatment for childhood malignancies have been shown to develop relative osteopenia following chemotherapy and are felt to be at risk for developing osteoporosis later in life due to their inability to reach peak bone mass during childhood.
Primary Outcome
Does chemotherapy increase the risk of osteoporosis in patients
Interventions
- RADIATION DXA Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2003-04 |
| Est. Completion | 2006-04 |
What the finished NCT00634816 record still lists
NCT00634816 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 38 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which DXA Scan is the first listed.
NCT00634816 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00634816 about?
NCT00634816 is a clinical study titled "Bone Mineral Density in Adult Survivors of Solid Pediatric Cancers". Specific subgroups of children who survive treatment for childhood malignancies have been shown to develop relative osteopenia following chemotherapy and are felt to be at risk for developing osteoporosis later in life due to their inability to reach peak bone mass during childhood.
What is the current status of trial NCT00634816?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2003-04. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00634816?
The interventions under investigation include: DXA Scan (RADIATION).
Who is sponsoring clinical trial NCT00634816?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia